Kings Point Capital Management’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$50K Buy
4,640
+1,469
+46% +$19.4K ﹤0.01% 347
2021
Q4
$43K Hold
3,171
﹤0.01% 412
2021
Q3
$43K Buy
+3,171
New +$45K ﹤0.01% 378
2021
Q1
Sell
-793
Closed -$15K 568
2020
Q4
$15K Buy
+793
New +$12.9K ﹤0.01% 457
2016
Q3
Sell
-309
Closed -$13K 335
2016
Q2
$13K Hold
309
﹤0.01% 306
2016
Q1
$14K Buy
+309
New +$14.9K ﹤0.01% 299

Other funds holding VTRS

Kings Point Capital Management's VTRS Position: Q1 2022 in Review

Kings Point Capital Management increased its Viatris (VTRS) stake by 46% in Q1 2022, buying an estimated $19.4K and bringing the position to 4,640 shares worth $50K. The position accounts for ﹤0.01% of the portfolio, ranked #347.

Kings Point Capital Management first reported a position in VTRS in Q1 2016 and has held it in 6 quarters since. 1,022 funds tracked by Wall St. Rank hold VTRS as of Q1 2022.

  • Kings Point Capital Management held 4,640 shares of Viatris worth $50K as of Q1 2022.
  • Kings Point Capital Management bought 1,469 Viatris shares in Q1 2022, an estimated $19.4K.
  • Viatris made up ﹤0.01% of Kings Point Capital Management's portfolio in Q1 2022, its #347 holding.
  • Kings Point Capital Management first reported a position in Viatris in Q1 2016 and has held it in 6 quarters since.
  • 1,022 funds tracked by Wall St. Rank held Viatris as of Q1 2022.

Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.